{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T23:03:40Z","timestamp":1791673420331,"version":"4.3.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T00:00:00Z","timestamp":1762732800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1D1A1B07049542, 2019R1A5A2027588, and 2019M3E5D3073104"],"award-info":[{"award-number":["2018R1D1A1B07049542, 2019R1A5A2027588, and 2019M3E5D3073104"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Cancer"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Although non-muscle-invasive bladder cancer (NMIBC) frequently recurs and progresses despite BCG therapy, cellular mechanisms behind this remain unclear. Understanding the dynamics within the tumor microenvironment (TME) and identifying pathways associated with BCG resistance are crucial for improving NMIBC treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>To elucidate transcriptional dynamics and key cellular interactions in the TME, we performed longitudinal single-nucleus RNA sequencing of 9 NMIBC cases with three pairs of treatment-na\u00efve and disease progression samples. The resulting 58,037 nuclei were subject to cell type and subtyping annotations along with cell\u2013cell interaction analyses.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Our analysis revealed marked interpatient heterogeneity in malignant cells, accompanied by copy number alterations associated with disease progression. TGF-\u03b2 signaling emerged as a key pathway, showing gradual enrichment from pre-treatment to post-progression samples. Within the tumor microenvironment, we identified distinct subtypes including\n                      <jats:italic>LAMP3<\/jats:italic>\n                      \u2009+\u2009dendritic cells and\n                      <jats:italic>iCAF<\/jats:italic>\n                      fibroblasts that followed unique pseudotime trajectories linked to progression. Cell\u2013cell interaction analysis further highlighted critical ligand\u2013receptor pairs such as\n                      <jats:italic>DSC2\u2013DSG2<\/jats:italic>\n                      and\n                      <jats:italic>ENG\u2013BMPR2<\/jats:italic>\n                      , which were associated with poor clinical outcomes. These interactions may represent hypothesis-generating candidates that warrant further validation.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study highlights key cellular and molecular mechanisms underlying bladder cancer progression Post-BCG treatment. Through single-nucleus RNA sequencing, we identified critical TME subtypes, TGF-\u03b2 signaling involvement, and crucial ligand-receptor interactions such as DSC2-DSG2 and ENG-BMPR2, which may serve as preliminary biomarkers requiring confirmation in larger independent cohorts. These findings offer valuable insights into enhancement of treatment strategies and patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12885-025-15079-8","type":"journal-article","created":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T11:43:44Z","timestamp":1762775024000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["TGF-\u03b2 signaling and tumor microenvironment dynamics in bladder cancer progression post-BCG therapy: a longitudinal single-nucleus RNA-seq study"],"prefix":"10.1186","volume":"25","author":[{"given":"Seo-Young","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Min","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U.-Syn","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,10]]},"reference":[{"issue":"1","key":"15079_CR1","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.eururo.2016.06.010","volume":"71","author":"S Antoni","year":"2017","unstructured":"Antoni S, Ferlay J, Soerjomataram I, Znaor A, Jemal A, Bray F. Bladder cancer incidence and mortality: a global overview and recent trends. Eur Urol. 2017;71(1):96\u2013108.","journal-title":"Eur Urol"},{"issue":"12","key":"15079_CR2","doi-asserted-by":"publisher","first-page":"3377","DOI":"10.1158\/1078-0432.CCR-12-0077-T","volume":"18","author":"G Sj\u00f6dahl","year":"2012","unstructured":"Sj\u00f6dahl G, Lauss M, L\u00f6vgren K, Chebil G, Gudjonsson S, Veerla S, et al. A molecular taxonomy for urothelial carcinoma. Clin Cancer Res. 2012;18(12):3377\u201386.","journal-title":"Clin Cancer Res"},{"issue":"4","key":"15079_CR3","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","volume":"196","author":"SS Chang","year":"2016","unstructured":"Chang SS, Boorjian SA, Chou R, Clark PE, Daneshmand S, Konety BR, et al. Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline. J Urol. 2016;196(4):1021\u20139.","journal-title":"J Urol"},{"issue":"1","key":"15079_CR4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","volume":"81","author":"M Babjuk","year":"2022","unstructured":"Babjuk M, Burger M, Capoun O, Cohen D, Comp\u00e9rat EM, Escrig JLD, et al. European Association of Urology guidelines on non-muscle-invasive bladder cancer (Ta, T1, and carcinoma in situ). Eur Urol. 2022;81(1):75\u201394.","journal-title":"Eur Urol"},{"issue":"2","key":"15079_CR5","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/S0022-5347(17)58737-6","volume":"116","author":"A Morales","year":"1976","unstructured":"Morales A, Eidinger D, Bruce AW. Intracavitary bacillus Calmette-Guerin in the treatment of superficial bladder tumors. J Urol. 1976;116(2):180\u20133.","journal-title":"J Urol"},{"issue":"12","key":"15079_CR6","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1177\/106002809102501215","volume":"25","author":"JT Moss","year":"1991","unstructured":"Moss JT, Kadmon D. Bcg and the treatment of superficial bladder-cancer. DICP. 1991;25(12):1355\u201367.","journal-title":"DICP"},{"key":"15079_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-22465-w","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog SV, Prip F, Lamy P, Taber A, Groeneveld CS, Birkenkamp-Demtr\u00f6der K, et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat Commun. 2021. https:\/\/doi.org\/10.1038\/s41467-021-22465-w.","journal-title":"Nat Commun"},{"issue":"5","key":"15079_CR8","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.21037\/tau-20-696","volume":"9","author":"Q Xing","year":"2020","unstructured":"Xing Q, Liu S, Jiang S, Li T, Wang Z, Wang Y. Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA). Transl Androl Urol. 2020;9(5):2054\u201370.","journal-title":"Transl Androl Urol"},{"issue":"12","key":"15079_CR9","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s00262-017-2047-2","volume":"66","author":"CW Shuptrine","year":"2017","unstructured":"Shuptrine CW, Ajina R, Fertig EJ, Jablonski SA, Kim Lyerly H, Hartman ZC, et al. An unbiased in vivo functional genomics screening approach in mice identifies novel tumor cell-based regulators of immune rejection. Cancer Immunol Immunother. 2017;66(12):1529\u201344.","journal-title":"Cancer Immunol Immunother"},{"issue":"7693","key":"15079_CR10","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/nature25501","volume":"554","author":"S Mariathasan","year":"2018","unstructured":"Mariathasan S, Turley SJ, Nickles D, Castiglioni A, Yuen K, Wang Y, et al. TGF\u03b2 attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells. Nature. 2018;554(7693):544\u20138.","journal-title":"Nature"},{"issue":"697","key":"15079_CR11","doi-asserted-by":"publisher","first-page":"eabn4118","DOI":"10.1126\/scitranslmed.abn4118","volume":"15","author":"FC de Jong","year":"2023","unstructured":"de Jong FC, Laajala TD, Hoedemaeker RF, Jordan KR, van der Made ACJ, Boeve ER, et al. Non-muscle-invasive bladder cancer molecular subtypes predict differential response to intravesical Bacillus Calmette-Guerin. Sci Transl Med. 2023;15(697):eabn4118.","journal-title":"Sci Transl Med"},{"issue":"7","key":"15079_CR12","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","volume":"177","author":"T Stuart","year":"2019","unstructured":"Stuart T, Butler A, Hoffman P, Hafemeister C, Papalexi E, Mauck WM 3rd, et al. Comprehensive Integration of Single-Cell Data. Cell. 2019;177(7):1888-1902 e1821.","journal-title":"Cell."},{"issue":"4","key":"15079_CR13","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.cels.2019.03.003","volume":"8","author":"CS McGinnis","year":"2019","unstructured":"McGinnis CS, Murrow LM, Gartner ZJ. DoubletFinder: Doublet Detection in Single-Cell RNA Sequencing Data Using Artificial Nearest Neighbors. Cell Syst. 2019;8(4):329-337 e324.","journal-title":"Cell Syst."},{"key":"15079_CR14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S Hanzelmann","year":"2013","unstructured":"Hanzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"4","key":"15079_CR15","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","volume":"32","author":"C Trapnell","year":"2014","unstructured":"Trapnell C, Cacchiarelli D, Grimsby J, Pokharel P, Li S, Morse M, et al. The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells. Nat Biotechnol. 2014;32(4):381\u20136.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"15079_CR16","doi-asserted-by":"publisher","first-page":"1088","DOI":"10.1038\/s41467-021-21246-9","volume":"12","author":"S Jin","year":"2021","unstructured":"Jin S, Guerrero-Juarez CF, Zhang L, Chang I, Ramos R, Kuan CH, et al. Inference and analysis of cell-cell communication using Cell Chat. Nat Commun. 2021;12(1):1088.","journal-title":"Nat Commun"},{"issue":"2","key":"15079_CR17","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1038\/s41592-019-0667-5","volume":"17","author":"R Browaeys","year":"2020","unstructured":"Browaeys R, Saelens W, Saeys Y. Nichenet: modeling intercellular communication by linking ligands to target genes. Nat Methods. 2020;17(2):159\u201362.","journal-title":"Nat Methods"},{"issue":"6","key":"15079_CR18","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1097\/CM9.0000000000002573","volume":"136","author":"X Jin","year":"2023","unstructured":"Jin X, Wang Q, Luo F, Pan J, Lu T, Zhao Y, et al. Single-cell transcriptomic analysis of tumor heterogeneity and intercellular networks in human urothelial carcinoma. Chin Med J (Engl). 2023;136(6):690\u2013706.","journal-title":"Chin Med J (Engl)"},{"key":"15079_CR19","doi-asserted-by":"publisher","first-page":"1105026","DOI":"10.3389\/fonc.2022.1105026","volume":"12","author":"Z Chen","year":"2022","unstructured":"Chen Z, Chen D, Song Z, Lv Y, Qi D. Mapping the tumor microenvironment in bladder cancer and exploring the prognostic genes by single-cell RNA sequencing. Front Oncol. 2022;12:1105026.","journal-title":"Front Oncol"},{"issue":"12","key":"15079_CR20","doi-asserted-by":"publisher","first-page":"2099","DOI":"10.1002\/ijc.33794","volume":"149","author":"H Lai","year":"2021","unstructured":"Lai H, Cheng X, Liu Q, Luo W, Liu M, Zhang M, et al. Single-cell RNA sequencing reveals the epithelial cell heterogeneity and invasive subpopulation in human bladder cancer. Int J Cancer. 2021;149(12):2099\u2013115.","journal-title":"Int J Cancer"},{"key":"15079_CR21","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202308438","author":"Y Xiao","year":"2024","unstructured":"Xiao Y, Jin W, Qian K, Ju L, Wang G, Wu K, et al. Integrative single cell atlas revealed intratumoral heterogeneity generation from an adaptive epigenetic cell state in human bladder urothelial carcinoma. Adv Sci. 2024. https:\/\/doi.org\/10.1002\/advs.202308438.","journal-title":"Adv Sci"},{"issue":"1","key":"15079_CR22","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13073-020-00741-6","volume":"12","author":"HW Lee","year":"2020","unstructured":"Lee HW, Chung W, Lee HO, Jeong DE, Jo A, Lim JE, et al. Single-cell RNA sequencing reveals the tumor microenvironment and facilitates strategic choices to circumvent treatment failure in a chemorefractory bladder cancer patient. Genome Med. 2020;12(1):47.","journal-title":"Genome Med"},{"key":"15079_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2021.100472","author":"CD Hurst","year":"2021","unstructured":"Hurst CD, Cheng G, Platt FM, Castro MAA, Marzouka NADS, Eriksson P, et al. Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight. Cell Rep Med. 2021. https:\/\/doi.org\/10.1016\/j.xcrm.2021.100472.","journal-title":"Cell Rep Med"},{"issue":"20","key":"15079_CR24","doi-asserted-by":"publisher","first-page":"4476","DOI":"10.1158\/0008-5472.CAN-20-0977","volume":"80","author":"J Bellmunt","year":"2020","unstructured":"Bellmunt J, Kim J, Reardon B, Perera-Bel J, Orsola A, Rodriguez-Vida A, et al. Genomic predictors of good outcome, recurrence, or progression in high-grade T1 non-muscle-invasive bladder cancer. Cancer Res. 2020;80(20):4476\u201386.","journal-title":"Cancer Res"},{"key":"15079_CR25","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-11-182","author":"V L\u00f3pez","year":"2013","unstructured":"L\u00f3pez V, Gonz\u00e1lez-Peramato P, Suela J, Serrano A, Algaba F, Cigudosa JC, et al. Identification of prefoldin amplification (1q23.3-q24.1) in bladder cancer using comparative genomic hybridization (CGH) arrays of urinary DNA. J Transl Med. 2013. https:\/\/doi.org\/10.1186\/1479-5876-11-182.","journal-title":"J Transl Med"},{"key":"15079_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18916-5","author":"ZH Chen","year":"2020","unstructured":"Chen ZH, Zhou LJ, Liu LL, Hou YX, Xiong M, Yang Y, et al. Single-cell RNA sequencing highlights the role of inflammatory cancer-associated fibroblasts in bladder urothelial carcinoma. Nat Commun. 2020. https:\/\/doi.org\/10.1038\/s41467-020-18916-5.","journal-title":"Nat Commun"},{"key":"15079_CR27","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2215744120","author":"ZW Gu","year":"2023","unstructured":"Gu ZW, Wang L, Dong Q, Xu KK, Ye JN, Shao XF, et al. Aberrant LYZ expression in tumor cells serves as the potential biomarker and target for HCC and promotes tumor progression via csGRP78. Proc Natl Acad Sci U S A. 2023. https:\/\/doi.org\/10.1073\/pnas.2215744120.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"24","key":"15079_CR28","doi-asserted-by":"publisher","first-page":"22354","DOI":"10.1002\/cam4.6715","volume":"12","author":"R He","year":"2023","unstructured":"He R, Zhang X, Wu YZ, Weng ZJ, Li LJ. TTC7B is a new prognostic biomarker in head and neck squamous cell carcinoma linked to immune infiltration and ferroptosis. Cancer Med. 2023;12(24):22354\u201369.","journal-title":"Cancer Med"},{"key":"15079_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249732","author":"Y Sawada","year":"2020","unstructured":"Sawada Y, Mashima E, Saito-Sasaki N, Nakamura M. The role of cell adhesion molecule 1 (CADM1) in cutaneous malignancies. Int J Mol Sci. 2020. https:\/\/doi.org\/10.3390\/ijms21249732.","journal-title":"Int J Mol Sci"},{"key":"15079_CR30","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233876","author":"HN Kang","year":"2022","unstructured":"Kang HN, Fichna J, Matlawska-Wasowska K, Jacenik D. The expression pattern of adhesion G protein-coupled receptor F5 is related to cell adhesion and metastatic pathways in colorectal cancer-comprehensive study based on in silico analysis. Cells. 2022. https:\/\/doi.org\/10.3390\/cells11233876.","journal-title":"Cells"},{"issue":"11","key":"15079_CR31","doi-asserted-by":"publisher","first-page":"2461","DOI":"10.1038\/s41423-021-00726-4","volume":"18","author":"J Liu","year":"2021","unstructured":"Liu J, Zhang XM, Cheng YJ, Cao XT. Dendritic cell migration in inflammation and immunity. Cell Mol Immunol. 2021;18(11):2461\u201371.","journal-title":"Cell Mol Immunol"},{"issue":"4","key":"15079_CR32","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.eururo.2022.01.026","volume":"81","author":"JA Nakauma-Gonz\u00e1lez","year":"2022","unstructured":"Nakauma-Gonz\u00e1lez JA, Rijnders M, van Riet J, van der Heijden MS, Voortman J, Cuppen E, et al. Comprehensive molecular characterization reveals genomic and transcriptomic subtypes of metastatic urothelial carcinoma. Eur Urol. 2022;81(4):331\u20136.","journal-title":"Eur Urol"},{"key":"15079_CR33","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1016\/j.csbj.2022.12.049","volume":"21","author":"J Zhang","year":"2023","unstructured":"Zhang J, Lu T, Lu S, Ma S, Han D, Zhang K, et al. Single-cell analysis of multiple cancer types reveals differences in endothelial cells between tumors and normal tissues. Comput Struct Biotechnol J. 2023;21:665\u201376.","journal-title":"Comput Struct Biotechnol J"},{"issue":"1","key":"15079_CR34","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","volume":"13","author":"J Qi","year":"2022","unstructured":"Qi J, Sun H, Zhang Y, Wang Z, Xun Z, Li Z, et al. Single-cell and spatial analysis reveal interaction of FAP(+) fibroblasts and SPP1(+) macrophages in colorectal cancer. Nat Commun. 2022;13(1):1742.","journal-title":"Nat Commun"},{"issue":"2","key":"15079_CR35","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1515\/mr-2021-0032","volume":"1","author":"J Wei","year":"2021","unstructured":"Wei J, Bu Z, Ji J. A commentary on: \u201cA pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells\u201d - tumor microenvironment: the Achilles heel of cancer. Med Rev. 2021;1(2):126\u20138.","journal-title":"Med Rev"},{"issue":"4","key":"15079_CR36","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1016\/j.jcmgh.2023.07.001","volume":"16","author":"J Huang","year":"2023","unstructured":"Huang J, Tsang WY, Li ZH, Guan XY. The origin, differentiation, and functions of cancer-associated fibroblasts in gastrointestinal cancer. Cell Mol Gastroenterol Hepatol. 2023;16(4):503\u201311.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"15079_CR37","doi-asserted-by":"crossref","unstructured":"Mosquera JV, Auguste G, Wong D, Turner AW, Hodonsky CJ, Alvarez-Yela AC, Song YP, Cheng Q, Cardenas CLL, Theofilatos K et al: Integrative single-cell meta-analysis reveals disease-relevant vascular cell states and markers in human atherosclerosis. Cell Reports. 2023;42(11):113380.","DOI":"10.1016\/j.celrep.2023.113380"},{"key":"15079_CR38","doi-asserted-by":"publisher","DOI":"10.1038\/s42003-020-01383-5","author":"S Koshiba","year":"2020","unstructured":"Koshiba S, Motoike IN, Saigusa D, Inoue J, Aoki Y, Tadaka S, et al. Identification of critical genetic variants associated with metabolic phenotypes of the Japanese population. Commun Biol. 2020. https:\/\/doi.org\/10.1038\/s42003-020-01383-5.","journal-title":"Commun Biol"},{"key":"15079_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0029099","author":"JM Douville","year":"2011","unstructured":"Douville JM, Cheung DYC, Herbert KL, Moffatt T, Wigle JT. Mechanisms of MEOX1 and MEOX2 regulation of the cyclin dependent kinase inhibitors p21 and p16 in vascular endothelial cells. PLoS One. 2011. https:\/\/doi.org\/10.1371\/journal.pone.0029099.","journal-title":"PLoS One"},{"issue":"6","key":"15079_CR40","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1161\/CIRCRESAHA.115.304718","volume":"115","author":"SF Rocha","year":"2014","unstructured":"Rocha SF, Schiller M, Jing D, Li H, Butz S, Vestweber D, et al. Esm1 modulates endothelial tip cell behavior and vascular permeability by enhancing VEGF bioavailability. Circ Res. 2014;115(6):581.","journal-title":"Circ Res"},{"key":"15079_CR41","doi-asserted-by":"crossref","unstructured":"Vivien CJ, Pichol-Thievend C, Sim CB, Smith JB, Bower NI, Hogan BM, Hudson JE, Francois M, Porrello ER: Vegfc\/d-dependent regulation of the lymphatic vasculature during cardiac regeneration is influenced by injury context. Npj Regenerative Medicine. 2019;4:18.","DOI":"10.1038\/s41536-019-0079-2"},{"issue":"7947","key":"15079_CR42","doi-asserted-by":"publisher","first-page":"343-+","DOI":"10.1038\/s41586-022-05650-9","volume":"614","author":"J Kazenwadel","year":"2023","unstructured":"Kazenwadel J, Venugopal P, Oszmiana A, Toubia J, Arriola-Martinez L, Panara V, et al. A enhancer represses haematopoiesis in the lymphatic vasculature. Nature. 2023;614(7947):343-+.","journal-title":"Nature."}],"container-title":["BMC Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15079-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12885-025-15079-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12885-025-15079-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T18:12:10Z","timestamp":1762884730000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmccancer.biomedcentral.com\/articles\/10.1186\/s12885-025-15079-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,10]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["15079"],"URL":"https:\/\/doi.org\/10.1186\/s12885-025-15079-8","relation":{},"ISSN":["1471-2407"],"issn-type":[{"value":"1471-2407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,10]]},"assertion":[{"value":"10 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures were conducted with informed consent from patients and approved by the Institutional Review Board of Seoul St. Mary\u2019s Hospital.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors reviewed the final version of the manuscript and approved it for publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1735"}}